Laryngeal dystonia: Phenomenology, genetics, and management.
3/5 보강
TL;DR
There is no cure for laryngeal dystonia, but botulinum toxin has shown significant success in treating the symptoms of the disorder.
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
1400 patients were diagnosed with laryngeal dystonia in the last thirty years.
I · Intervention 중재 / 시술
toxin to the thyroarytenoid muscles and those with abductor dystonia were treated with toxin to the posterior cricoarytenoid muscle
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
We also summarize the underlying genetics of the disorder.
연도별 인용 (2023–2025) · 합계 6
OpenAlex 토픽 ·
Voice and Speech Disorders
Botulinum Toxin and Related Neurological Disorders
Neurological disorders and treatments
There is no cure for laryngeal dystonia, but botulinum toxin has shown significant success in treating the symptoms of the disorder.
APA
Andrew Blitzer, Nikita Kohli (2023). Laryngeal dystonia: Phenomenology, genetics, and management.. Toxicon : official journal of the International Society on Toxinology, 233, 107258. https://doi.org/10.1016/j.toxicon.2023.107258
MLA
Andrew Blitzer, et al.. "Laryngeal dystonia: Phenomenology, genetics, and management.." Toxicon : official journal of the International Society on Toxinology, vol. 233, 2023, pp. 107258.
PMID
37647998 ↗
Abstract 한글 요약
Laryngeal dystonia is a task-specific movement disorder causing abnormal movement of the adductor or abductor muscles of the vocal folds. In 1984, Blitzer pioneered the first use of onabotulinum toxin A to treat this disorder. Over 1400 patients were diagnosed with laryngeal dystonia in the last thirty years. In this paper, we summarize their clinical and endoscopic findings as well as treatment results. We also summarize the underlying genetics of the disorder. 82% of patients were diagnosed with adductor type laryngeal dystonia and 17% of patients manifested an abductor laryngeal dystonia. Patients with adductor dystonia were treated with toxin to the thyroarytenoid muscles and those with abductor dystonia were treated with toxin to the posterior cricoarytenoid muscle. All patient achieved greater than 70% improvement in percent normal function. Laryngeal dystonia is a rare movement disorder of the larynx with an incidence of approximately 35.1 per 100,000 individuals (Simonyan et al., 2021). Presently, there is no cure for laryngeal dystonia, but botulinum toxin has shown significant success in treating the symptoms of the disorder.
추출된 의학 개체 (NER)
시술
보툴리눔독소 주사
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 기법 | endoscopic
|
내시경 | dict | 1 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능
- Mechanisms of Botulinum Toxin Type A Action on Pain.
- Effect of Botulinum Toxin Injection on EMG Activity and Bite Force in Masticatory Muscle Disorder: A Randomized Clinical Trial.
- Botulinum Toxin: An Update on Pharmacology and Newer Products in Development.
- Immunogenicity of botulinum toxin.
- Botulinum Toxin in the Treatment of Headache.